These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 25958256)

  • 1. Procollagen type III amino terminal peptide and myocardial fibrosis: A study in hypertensive patients with and without left ventricular hypertrophy.
    dos Santos Moreira C; Serejo F; Alcântara P; Ramalhinho V; Braz Nogueira J
    Rev Port Cardiol; 2015 May; 34(5):309-14. PubMed ID: 25958256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased serum concentrations of procollagen peptides in essential hypertension. Relation to cardiac alterations.
    Díez J; Laviades C; Mayor G; Gil MJ; Monreal I
    Circulation; 1995 Mar; 91(5):1450-6. PubMed ID: 7867186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor beta in hypertensives with cardiorenal damage.
    Laviades C; Varo N; Díez J
    Hypertension; 2000 Oct; 36(4):517-22. PubMed ID: 11040229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor I and collagen type III synthesis in patients with essential hypertension and left ventricular hypertrophy.
    Diéz J; Laviades C
    J Hum Hypertens; 1994 Sep; 8 Suppl 1():S21-5. PubMed ID: 7807509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The regression of left ventricular hypertrophy by imidapril and the reduction of serum procollagen type III amino-terminal peptide in hypertensive patients.
    Sasaguri M; Noda K; Tashiro E; Notomo J; Tsuji E; Koga M; Arakawa K
    Hypertens Res; 2000 Jul; 23(4):317-22. PubMed ID: 10912767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Procollagen type I carboxy-terminal peptide shows left ventricular hypertrophy and diastolic dysfunction in hypertensive patients.
    Demir M; Acartürk E; Inal T; Attila G; Dönmez Y; Avkaroğullari M; Cayli M
    Cardiovasc Pathol; 2007; 16(2):69-74. PubMed ID: 17317538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased collagen type I synthesis in patients with heart failure of hypertensive origin: relation to myocardial fibrosis.
    Querejeta R; López B; González A; Sánchez E; Larman M; Martínez Ubago JL; Díez J
    Circulation; 2004 Sep; 110(10):1263-8. PubMed ID: 15313958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left ventricular hypertrophy and geometry in untreated essential hypertension is associated with blood levels of aldosterone and procollagen type III amino-terminal peptide.
    Nakahara T; Takata Y; Hirayama Y; Asano K; Adachi H; Shiokawa G; Sumi T; Ogawa T; Yamashina A
    Circ J; 2007 May; 71(5):716-21. PubMed ID: 17456997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with lisinopril normalizes serum concentrations of procollagen type III amino-terminal peptide in patients with essential hypertension.
    Laviades C; Mayor G; Díez J
    Am J Hypertens; 1994 Jan; 7(1):52-8. PubMed ID: 8136111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toward the biochemical assessment of myocardial fibrosis in hypertensive patients.
    Díez J; Laviades C; Monreal I; Gil MJ; Panizo A; Pardo J
    Am J Cardiol; 1995 Nov; 76(13):14D-17D. PubMed ID: 7495211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cardial fibrosis and the functional activity of leukocytes in patients with essential arterial hypertension].
    Moiseeva OM; Aleshina GM; Ivanova TG; Kokriakov VN; Shliakhto EV
    Vestn Ross Akad Med Nauk; 2006; (8):3-7. PubMed ID: 17002017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of myocardial diastolic dysfunction on coronary flow reserve in hypertensive patients with left ventricular hypertrophy.
    Galderisi M; Cicala S; De Simone L; Caso P; Petrocelli A; Pietropaolo L; Celentano A; Mininni N; de Divitiis O
    Ital Heart J; 2001 Sep; 2(9):677-84. PubMed ID: 11666096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of the PPARGC1A Gly482Ser polymorphism on left ventricular structural and functional abnormalities in patients with hypertension.
    Rojek A; Cielecka-Prynda M; Przewlocka-Kosmala M; Laczmanski L; Mysiak A; Kosmala W
    J Hum Hypertens; 2014 Sep; 28(9):557-63. PubMed ID: 24718382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation of circulating markers of fibrosis and progression of left and right ventricular dysfunction in hypertensive patients with heart failure.
    Plaksej R; Kosmala W; Frantz S; Herrmann S; Niemann M; Störk S; Wachter R; Angermann CE; Ertl G; Bijnens B; Weidemann F
    J Hypertens; 2009 Dec; 27(12):2483-91. PubMed ID: 19887955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma B-type natriuretic peptide reflects left ventricular hypertrophy and diastolic function in hypertension.
    Uusimaa P; Tokola H; Ylitalo A; Vuolteenaho O; Ruskoaho H; Risteli J; Linnaluoto M; Peuhkurinen K;
    Int J Cardiol; 2004 Nov; 97(2):251-6. PubMed ID: 15458692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is plasma cardiotrophin-1 a marker of hypertensive heart disease?
    López B; González A; Lasarte JJ; Sarobe P; Borrás F; Díaz A; Barba J; Tomás L; Lozano E; Serrano M; Varo N; Beloqui O; Fortuño MA; Díez J
    J Hypertens; 2005 Mar; 23(3):625-32. PubMed ID: 15716706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Left ventricular mass, diastolic function and collagen metabolism biomarkers in essential hypertension].
    Macías Blanco C; Fatela-Cantillo D; Jiménez-Jiménez L; López Aguilar R; Moreno-Luna R; Doblas Delgado A; Stiefel P
    Med Clin (Barc); 2012 Feb; 138(4):139-44. PubMed ID: 21939991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma tissue inhibitor of metalloproteinase-1 levels are elevated in essential hypertension and related to left ventricular hypertrophy.
    Timms PM; Wright A; Maxwell P; Campbell S; Dawnay AB; Srikanthan V
    Am J Hypertens; 2002 Mar; 15(3):269-72. PubMed ID: 11939619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial fibrosis and diastolic dysfunction in patients with hypertension: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA).
    Müller-Brunotte R; Kahan T; López B; Edner M; González A; Díez J; Malmqvist K
    J Hypertens; 2007 Sep; 25(9):1958-66. PubMed ID: 17762662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Arrhythmogenicity in left ventricular hypertrophy in mild to moderate arterial hypertension].
    Franchi F; Michelucci A; Padeletti L; Monopoli A; Fabbri G; Cersosimo RM; Mezzani A
    G Ital Cardiol; 1992 Aug; 22(8):905-18. PubMed ID: 1478391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.